Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biomatrix (BXM) Looking Great -- Ignore unavailable to you. Want to Upgrade?

To: John McCarthy who wrote (187)	11/16/1997 5:59:00 AM
From: James Baker	Read Replies (1) \| Respond to of 569

John, I posted this in reply to you on the ANIK board since it applies to BIOX I will repost it here: I agree with you <<<It looks like BMY has one of the best ORTHO sales forces ....>>> As a BIOX stock owner I was a bit concerned to see this news. The competition will be a factor. We still don't have a clear view of which product is better (high or low molecular wt? better mechanical action? fewer adverse reactions?) if either truly is. One thought about Zimmer is that they are very big in ortho appliances (joint replacement etc) and their contacts will be great with ortho surgeons. I hope that BIOX and WA will have good coverage there also but will be even stronger in the medical specalists (internal med, family proctice and rheumatology) where Synvisc might be a great addition to their care. Surgeons still like to DO surgery. Although they will use these products more patients in the hands of surgeons are going to end up getting surgery. Jim